Literature DB >> 11159961

Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection.

N R Salama1, G Otto, L Tompkins, S Falkow.   

Abstract

Helicobacter pylori, the causative agent of gastritis and ulcer disease in humans, secretes a toxin called VacA (vacuolating cytotoxin) into culture supernatants. VacA was initially characterized and purified on the basis of its ability to induce the formation of intracellular vacuoles in tissue culture cells. H. pylori strains possessing different alleles of vacA differ in their ability to express active toxin. Those strains expressing higher toxin levels are correlated with more severe gastric disease. However, the specific role(s) played by VacA during the course of infection and disease is not clear. We have used a mouse model of H. pylori infection to begin to address this role. A null mutation of vacA compromises H. pylori in its ability to initially establish infection. If an infection by a vacA mutant is established, the bacterial load and degree of inflammation are similar to those associated with an isogenic wild-type strain. Thus, in this infection model, vacA plays a role in the initial colonization of the host, suggesting that strains of H. pylori expressing active alleles of vacA may be better adapted for host-to-host transmission.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159961      PMCID: PMC97945          DOI: 10.1128/IAI.69.2.730-736.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin.

Authors:  M Gerhard; N Lehn; N Neumayer; T Borén; R Rad; W Schepp; S Miehlke; M Classen; C Prinz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments.

Authors:  E Papini; M de Bernard; E Milia; M Bugnoli; M Zerial; R Rappuoli; C Montecucco
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

3.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.

Authors:  A C Wotherspoon; C Doglioni; T C Diss; L Pan; A Moschini; M de Boni; P G Isaacson
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

4.  Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori.

Authors:  S H Phadnis; D Ilver; L Janzon; S Normark; T U Westblom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

6.  Gastritis associated with infection by Helicobacter pylori in humans: geographical differences.

Authors:  T A Bertram; P D Murray; D R Morgan; G Jerdak; P Yang; S Czinn
Journal:  Scand J Gastroenterol Suppl       Date:  1991

Review 7.  Gastric bacteria other than Helicobacter pylori.

Authors:  A Lee; J O'Rourke
Journal:  Gastroenterol Clin North Am       Date:  1993-03       Impact factor: 3.806

8.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

Authors:  A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

9.  Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity.

Authors:  I Szabò; S Brutsche; F Tombola; M Moschioni; B Satin; J L Telford; R Rappuoli; C Montecucco; E Papini; M Zoratti
Journal:  EMBO J       Date:  1999-10-15       Impact factor: 11.598

10.  Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.

Authors:  J L Telford; P Ghiara; M Dell'Orco; M Comanducci; D Burroni; M Bugnoli; M F Tecce; S Censini; A Covacci; Z Xiang
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  88 in total

1.  Helicobacter pylori uses motility for initial colonization and to attain robust infection.

Authors:  Karen M Ottemann; Andrew C Lowenthal
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

Review 2.  VacA pores as portable portals for urea.

Authors:  J L Merchant
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin.

Authors:  Hetal K Patel; David C Willhite; Rakhi M Patel; Dan Ye; Christopher L Williams; Eric M Torres; Kent B Marty; Robert A MacDonald; Steven R Blanke
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

4.  Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolating cytotoxin within mammalian cells.

Authors:  David C Willhite; Dan Ye; Steven R Blanke
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 5.  Interactions between bacterial pathogens and mitochondrial cell death pathways.

Authors:  Thomas Rudel; Oliver Kepp; Vera Kozjak-Pavlovic
Journal:  Nat Rev Microbiol       Date:  2010-09-06       Impact factor: 60.633

6.  Helicobacter pylori VacA cytotoxin: a probe for a clathrin-independent and Cdc42-dependent pinocytic pathway routed to late endosomes.

Authors:  Nils C Gauthier; Pascale Monzo; Vincent Kaddai; Anne Doye; Vittorio Ricci; Patrice Boquet
Journal:  Mol Biol Cell       Date:  2005-07-29       Impact factor: 4.138

7.  Helicobacter pylori γ-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance.

Authors:  Mathias Oertli; Manuel Noben; Daniela B Engler; Raphaela P Semper; Sebastian Reuter; Joachim Maxeiner; Markus Gerhard; Christian Taube; Anne Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants.

Authors:  Rhonda R Caston; Johanna C Sierra; Nora J Foegeding; Mandy D Truelock; Anne M Campbell; Arwen E Frick-Cheng; Diane Bimczok; Keith T Wilson; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

9.  Helicobacter pylori protein-specific antibodies and risk of colorectal cancer.

Authors:  Meira Epplein; Michael Pawlita; Angelika Michel; Richard M Peek; Qiuyin Cai; William J Blot
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

10.  Resistance of primary murine CD4+ T cells to Helicobacter pylori vacuolating cytotoxin.

Authors:  Holly M Scott Algood; Victor J Torres; Derya Unutmaz; Timothy L Cover
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.